We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vialogy | LSE:VIY | London | Ordinary Share | GB0031647653 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.205 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/6/2014 13:02 | its BMD he "tipped" UKOG 100% ago..... | moreforus | |
26/6/2014 12:13 | article published today, don't know much about the site or guerilla investing, whatever that is! | the prophet | |
26/6/2014 12:10 | I ruminated on the discussion about the likely oversubscription for the extra shares we had yesterday and bought 2 million this morning below 13p! It looks like a good decision at present but we will see. I think the new company has excellent prospects both short and medium term. GLA Nobby | nobbygnome | |
26/6/2014 11:21 | Thanks TP im still averaging down but it certainly is getting expensive. | jacknash | |
26/6/2014 11:07 | page 26 of ad. document, link in the header, re share consolidation 10. SHARE CONSOLIDATION The Placing and Open Offer are conditional upon the approval and completion of the Proposals, including the Share Consolidation. The Company's Existing Ordinary Share Capital comprises 2,689,460,366 Existing Ordinary Shares. Resolution 4 to be proposed at the General Meeting proposes that every 100 Existing Ordinary Shares of the Company be consolidated into one New Ordinary Share. Holders of fewer than 100 Existing Ordinary Shares will not be entitled to receive a New Ordinary Share following the Share Consolidation. Shareholders with a holding in excess of 100 Existing Ordinary Shares, but which is not exactly divisible by 100, will have their holding of New Ordinary Shares rounded down to the nearest whole number of New Ordinary Shares following the Share Consolidation. Fractional entitlements, whether arising from holdings of fewer or more than 100 Existing Ordinary Shares, will be aggregated and sold in the market and the proceeds will be retained for the benefit of the Company. The New Ordinary Shares will continue to carry the same rights as attached to them immediately prior to the Share Consolidation as set out in the New Articles and will continue to be traded on AIM. The Company will issue new share certificates to those Shareholders holding shares in certificated form to take account of the Change of Name and the Share Consolidation. Following the issue of new share certificates, share certificates in respect of Existing Ordinary Shares will no longer be valid. Shareholders will still be able to trade in Ordinary Shares during the period between the passing of the Resolutions and the date on which Shareholders receive new share certificates. The Deferred Shares will not be affected by the Share Consolidation. Further details of the Share Consolidation are set out in paragraph 5 of Part IX of this document | the prophet | |
26/6/2014 11:02 | Yes, that is correct jn | the prophet | |
26/6/2014 10:59 | TP Am i correct.....buy 1m @ 0.13 = £1300 now,then consolidation brings shares amount holding to 10,000 @ 13p. | jacknash | |
25/6/2014 19:52 | you're all heart! | the prophet | |
25/6/2014 18:20 | mmm just gutted for the longterm holders | jammytass | |
25/6/2014 18:10 | jammytass Not spinning anything, and definitely not spinning Vialogy, it might have escaped your attention, but Vialogy is about to become Premaitha Health, using Vialogy as the shell to reverse into. New business, new board. Folks can make their own minds up on the prospects for Premaitha, but certainly the new board is a very strong one with good track records. The admission document for Premaitha is in the header. imo, very little to no point at all banging on about Vialogy. Yes , it didn't work, that often happens for tech companies trying to introduce new technology. Well done to you for calling it right but that has bog all to do with the future prospects here, which is what it is all about now. | the prophet | |
25/6/2014 17:58 | tp still spinning the bull for viy many many times i told u and the other holders that this cmpy was a con john d mullins lol wilfred strapp lol so called deals that where iffy lol well shafted by the so called shareholders chump bondo | jammytass | |
25/6/2014 17:46 | Thanks TP...feeling a bit stupid now :) | spec7 | |
25/6/2014 17:05 | understand you may have missed it Spec, but that was one of the very first things I posted when the admission document was published, as i thought it might confuse a few. Oh well, as Twix has pointed out, there ain't too much of a premium to buy in the market, least not for now. | the prophet | |
25/6/2014 16:59 | Nobby Thanks for putting me right on that ! no wonder i thought it was a pointless exercise for me at 400:1 with just 4m in my account, had i realised it was 4:1 i might have made a bit more of an effort :) My problem is i am trying to run a business and keep half an eye on this stuff and TBH i just don't have time to do the shares properly these days. Thanks again. | spec7 | |
25/6/2014 12:04 | With regard to the test, the important point is that this is more sensitive and more specific than other tests. That means that not only are more positives detected but also there are far fewer false positives. In addition, they are targeting sales through the existing pre natal screening sites and not competing against them. To me that is a very good strategy. Nobby | nobbygnome | |
25/6/2014 11:58 | >> Spec It is 1 for 4 of your original holding so I think it is misleading to say 1/400. That is true post consolidation but that is not the appropriate way of expressing it. Nobby | nobbygnome | |
25/6/2014 11:09 | One other thing. My feeling with the last crowd was they never raised enough money. the placings were always for 6 months or so. i hope this lot do not do the same thing. they have the opportunity to raise big money here. probably over subcribed. I'm sure if they had set the target at 200:1 more would have taken them up. I realise its just further dilution but better now just before consolidation than 6 months after and before the product hits market. another pacing because a good acquisition crops up before we have the first set of annual accounts following some proper sales will be a mistake. Far better to be cash rich now, if they start placing at 10-12p in a year people will see it as a slippery slope. | spec7 | |
25/6/2014 09:44 | Accepted Spec7, Most posters and shareholders I read/know are going for the Excess offer. imv it has to be scaled back significantly and more than the last one when we had no business details. I agree the .03p premium TODAY means little and I think buying in the market makes (more) sense at these levels than getting scaled down in the excess and having funds returned weeks later when price is (likely) significantly higher. I applied early and have since spent half my expected funds returned, to buy in the market as I am fine even if I get my full excess entitlement, though I expect 60% would be a result in reality. Where I accept, is this is aimho and for those who are minded to apply for the Excess offer and I could be wrong - maybe the price will be lower when funds eventually returned, but I sure don't expect so, so those who are going for excess have some thinking to do at just a .025p/.03p premium to offer price in today's market and to get filled in full along with getting the entitled open offer shares at 0.11p of course ;-) | twix386 | |
25/6/2014 09:30 | I have to disagree, i have not increased my holding but i do hope i am wrong. That said at 400:1 it was not exactly a huge amount for me anyway and if i really needed more the premium of .03p is not that great. I cant get excited by this until i see some tangible facts but as a punt it has legs. Plus side is the management, the product if it gets CE approval and accepted by the NHS approval panel. Minus side is it needs the plus side first. It has no US approval planned, it is not the only test, they don't have another string to their bow ...yet. It is early days and i dont think we have been given the full story yet but as most of us are here by default , so to speak, we might as well sit it out and hope for the best :-) | spec7 | |
25/6/2014 09:21 | I've done a bit of both too Prophet, though gone one stage further........ I expect to get a maximum of half my excess application and have used a cash-float meantime to buy in market and have that cost eventually refunded from my unused Excess application when funds returned. Not the end of the world if I get the full Excess entitlement and have spent my cash-float, but I think, as opposed to last time now we have the details, just about everyone is applying for excess. I think we will get a fraction of our applications - half at most and by the time funds returned we will be buying any balance at possibly up to double the offer price or settling for fewer. WE WILL SEE ;-) | twix386 | |
25/6/2014 09:14 | twix I think you are right there,not expecting too many in the excess bit, but I don't think .13p of thereabouts to buy will last for too long. I've hedged me bets and done a bit of both. | the prophet | |
25/6/2014 09:11 | virtually everyone is applying for excess/extras, so likely to be heavily scaled down imho. May be best to just buy here/now with the those funds in full in the market iro 0.13p instead, rather than to get a pittance in Excess at 0.11p and then wait and wait for funds to be returned, as by then share price (likely to be) 0.15p/0.2p imv. Just a thought | twix386 | |
25/6/2014 08:46 | I have subscribed for extras, every little helps! | the prophet | |
25/6/2014 08:44 | Out of interest who is over subscribing for shares? Seems like a no brainer to me so I have applied for a big extra chunk! Not sure that I will get most of them but it will be interesting to see. Nobby | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions